Quantifying the cardiometabolic burden of increasing BMI: associations with blood pressure, lipids, glucose, insulin resistance, atherogenic dyslipidemia, and metabolic syndrome in Spanish workers
Aug 2026· Academic Journal of Health Sciences· 0 citations
TL;DR
increasing BMI is associated with a substantial and progressive cardiometabolic burden characterized by worsening blood pressure, glucose metabolism, insulin resistance, lipid abnormalities, atherogenic dyslipidemia, and metabolic syndrome, highlighting the importance of early prevention and weight-management strategies before obesity becomes established.
Abstract
Background: Body mass index (BMI) is widely used to assess obesity-related health risks; however, the magnitude of cardiometabolic deterioration associated with incremental increases in BMI remains insufficiently quantified. This study aimed to evaluate the cardiometabolic burden associated with increasing BMI in a large cohort of Spanish workers. Methods: A cross-sectional study was conducted among 386,924 Spanish workers who underwent routine occupational health examinations between 2019 and 2024. Associations between BMI and cardiometabolic risk markers were assessed using multivariable linear and logistic regression analyses. Outcomes included systolic and diastolic blood pressure, fasting glucose, lipid profile, triglyceride-glucose (TyG) index, atherogenic dyslipidemia, and metabolic syndrome defined according to the NCEP ATP III, IDF, and JIS criteria. Receiver operating characteristic (ROC) analyses were performed to evaluate the discriminatory capacity of BMI. Results: Increasing BMI was associated with progressive deterioration in all cardiometabolic parameters. In fully adjusted models, each 1 kg/m² increase in BMI was associated with increases of 0.85 mmHg in systolic blood pressure, 0.64 mmHg in diastolic blood pressure, 0.36 mg/dL in fasting glucose, and 0.006 units in the TyG index (all p < 0.001). BMI was also independently associated with a higher likelihood of atherogenic dyslipidemia (OR: 1.031; 95% CI: 1.027–1.035) and metabolic syndrome according to ATP III (OR: 1.132; 95% CI: 1.129–1.135), IDF (OR: 1.198; 95% CI: 1.195–1.202), and JIS criteria (OR: 1.156; 95% CI: 1.153–1.159). A pronounced dose–response relationship was observed across BMI categories. BMI demonstrated good discriminatory capacity for identifying metabolic syndrome, with AUC values ranging from 0.797 to 0.843 and optimal thresholds close to 27 kg/m². Conclusions: Increasing BMI is associated with a substantial and progressive cardiometabolic burden characterized by worsening blood pressure, glucose metabolism, insulin resistance, lipid abnormalities, atherogenic dyslipidemia, and metabolic syndrome. Cardiometabolic risk increases across the entire BMI spectrum, highlighting the importance of early prevention and weight-management strategies before obesity becomes established.
Obesity is a major risk factor for cardiometabolic disease, but which indicator best identifies elevated risk remains uncertain. This cross-sectional study compared the associations and discriminatory ability of body mass index (BMI), percent body fat (PBF), waist circumference (WC), and waist-to-height ratio (WHtR) fo...
Eunok Park· Biological Research for Nurs...· 0 citations
Increases in BMI and WHtR were consistently associated with higher risks of hypertension, dyslipidemia, hyperuricemia, hyperuricemia, and early CKM stage progression across baseline body size categories.
Shinta Yamamoto, Hiroshi Okada, Tomohiro Shinozaki et al.· Diabetes, obesity and metabo...· 0 citations
Growing evidence suggests that composite metabolic indices may offer valuable insights into obesity-related complications. The Cardiometabolic Index (CMI), a surrogate marker of adverse lipid profiles and central adiposity, has emerged as a promising indicator of cardiometabolic risk. Nevertheless, its association with...
Amr A. El-Sehrawy, Ismail Kandil, M. Maashi et al.· Scientific Reports· 0 citations
PURPOSE
This study aimed to compare the associations and predictive performance of atherogenic index of plasma (AIP) and the triglyceride-glucose (TyG) index for incident cardiometabolic multimorbidity (CMM).
METHODS
Data was analyzed from 2261 adults (mean age 63 years; 45.0% men) in the English Longitudinal Study o...
S. Kunutsor, S. Jae, J. Laukkanen· Primary Care Diabetes· 0 citations
Background: The Cardiometabolic index (CMI), a composite marker that combines atherogenic dyslipidemia, mainly triglyceride to high density lipoprotein cholesterol (TG/HDL-C) ratio, with central adiposity, is determined by the waist to height ratio (WHtR). The objective of this study was to examine the diagnostic perfo...
BACKGROUND
The cardiometabolic index (CMI), a composite marker derived from the product of waist-to-height ratio and triglyceride-to- high-density lipoprotein cholesterol ratio, has emerged as a potential indicator of metabolic risk. However, the prognostic value of the CMI across diverse populations and the continuum...
Zhen-Yu Liu, Zhi-Xin Li, Si-Yan Huo et al.· Heart, Lung and Circulation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.